Scientists call for moratorium on clinical use of human germline editingBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6603 (Published 07 December 2015) Cite this as: BMJ 2015;351:h6603
- Michael McCarthy
An international group of scientists ended a three day forum in Washington, DC, USA, with a call for a moratorium on the clinical use of gene editing that involves alterations in the genomes of human germline cells.
The forum, the International Summit on Human Gene Editing, was prompted by recent advances in gene editing technologies, such as CRISPR-Cas9, that have made it much easier to make precise changes in the human genome.
The meeting was co-hosted by the US National Academy of Sciences, the US National Academy of Medicine, the Chinese Academy of Sciences, and the UK Royal Society. David Baltimore, president emeritus of the California Institute of Technology in Pasadena, California, was the summit’s chair.
In a statement …
Log in using your username and password
Log in through your institution
Sign up for a free trial